Cyclic neoglycodecapeptides: How to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells

Journal of Peptide Science

Volumn 17, Issue 6, 2011, Pages 427-437

  André, Sabine ^a   Renaudet, Olivier ^b   Bossu, Isabelle ^b   Dumy, Pascal ^b   Gabius, Hans Joachim ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITÉ JOSEPH FOURIER   (France)

Author keywords

Agglutinin; Colon cancer; Glycocluster; Glycopeptide; Lectin; Oxime ligation; Sialylation

Indexed keywords

GALACTOSE; GALECTIN; GLYCAN; GLYCOPEPTIDE; GLYCOPROTEIN; LACTOSE; LECTIN; PLANT LECTIN; TOXIN;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LECTIN BINDING; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ALPHA-FETOPROTEINS; ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ASIALOGLYCOPROTEINS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; GALACTOSE; GLYCOPEPTIDES; HUMANS; HYDROXYLAMINES; IMMOBILIZED PROTEINS; LACTOSE; LECTINS; PEPTIDES, CYCLIC;

TETRA;

EID: 79955888952     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1338     Document Type: Article

References (82)

1. The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009.
2. Gabius H-J. Cell surface glycans: the why and how of their functionality as biochemical signals in lectin-mediated information transfer. Crit. Rev. Immunol. 2006; 26: 43-79.
3. Zuber C, Roth J. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 87-110.
4. Patsos G, Corfield A. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 111-137.
5. Kopitz J. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 177-198.
6. Lee RT, Lee YC. In Glycosciences: Status and Perspectives, Gabius H-J, Gabius S (eds). Weinheim: Chapman & Hall: 1997; 55-77.
7. Fulton DA, Stoddart JF. Neoglycoconjugates based on cyclodextrins and calixarenes. Bioconjug. Chem. 2001; 12: 655-672.
8. Baldini L, Casnati A, Sansone F, Ungaro R. Calixarene-based multivalent ligands. Chem. Soc. Rev. 2007; 36: 254-266.
9. Boturyn D, Defrancq E, Dolphin GT, Garcia J, Labbe P, Renaudet O, Dumy P. RAFT nano-constructs: surfing to biological applications. J. Pept. Sci. 2008; 14: 224-240.
10. Niederhafner P, Šebestík J, Ježek J. Glycopeptide dendrimers. Part I. J. Pept. Sci. 2008; 14: 2-43.
11. Niederhafner P, Šebestík J, Ježek J. Glycopeptide dendrimers. Part II. J. Pept. Sci. 2008; 14: 44-65.
12. Chabre YM, Roy R. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 53-70.
13. Burke SD, Zhao Y, Schuster MC, Kiessling LL. Synergistic formation of soluble lectin clusters by a templated multivalent saccharide ligand. J. Am. Chem. Soc. 2000; 122: 4518-4519.
14. Hasegawa T, Yonemura T, Matsuura K, Kobayashi K. Tris-bipyridine ruthenium complex-based glycoclusters: amplified luminescence and enhanced lectin affinities. Tetrahedron Lett. 2001; 42: 3989-3992.
15. Roy R, Kim JM. Cu(II)-self-assembling bipyridyl-glycoclusters and dendrimers bearing the Tn-antigen cancer marker: syntheses and lectin binding properties. Tetrahedron 2003; 59: 3881-3893.
16. André S, Kaltner H, Furuike T, Nishimura S-I, Gabius H-J. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets. Bioconjug. Chem. 2004; 15: 87-98.
17. Pandey SK, Zheng X, Morgan J, Missert JR, Liu T-H, Shibata M, Bellnier DA, Oseroff AR, Henderson BW, Dougherty TJ, Pandey RK. Purpurinimide carbohydrate conjugates: effect of the position of the carbohydrate moiety in photosensitizing efficacy. Mol. Pharm. 2007; 4: 448-464.
18. André S, Sansone F, Kaltner H, Casnati A, Kopitz J, Gabius H-J, Ungaro R. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins. ChemBioChem 2008; 9: 1649-1661.
19. Leyden R, Velasco-Torrijos T, André S, Gouin S, Gabius H-J, Murphy PV. Synthesis of bivalent lactosides based on terephthalamide, N, N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins. J. Org. Chem. 2009; 74: 9010-9026.
20. xN-glycopeptides: effective ligands for E-selectin. Angew. Chem. Int. Ed. 1996; 35: 321-324.
21. Franzyk H, Christensen MK, Jørgensen RM, Meldal M, Cordes H, Mouritsen S, Bock K. Constrained glycopeptide ligands for MPRs. Limitations of unprotected phosphorylated building blocks. Bioorg. Med. Chem. 1997; 5: 21-40.
22. Wittmann V, Seeberger S. Combinatorial solid-phase synthesis of multivalent cyclic neoglycopeptides. Angew. Chem. Int. Ed. 2000; 39: 4348-4352.
23. Wittmann V, Seeberger S. Spatial screening of cyclic neoglycopeptides: identification of polyvalent wheat-germ agglutinin ligands. Angew. Chem. Int. Ed. 2004; 43: 900-903.
24. Renaudet O. Recent advances on cyclopeptide-based glycoclusters. Mini-Rev. Org. Chem. 2008; 5: 274-286.
25. Renaudet O, Dumy P. On-bead synthesis and binding assay of chemoselectively template-assembled multivalent neoglycopeptides. Org. Biomol. Chem. 2006; 4: 2628-2636.
26. Renaudet O, Dumy P. Chemoselectively template-assembled glycoconjugates as mimics for multivalent presentation of carbohydrates. Org. Lett. 2003; 5: 243-246.
27. Singh Y, Renaudet O, Defrancq E, Dumy P. Preparation of a multitopic glycopeptide-oligonucleotide conjugate. Org. Lett. 2005; 7: 1359-1362.
28. Renaudet O, Dumy P. Synthesis of multitopic neoglycopeptides displaying recognition and detection motifs. Bioorg. Med. Chem. Lett. 2005; 15: 3619-3622.
29. Dubois M-P, Gondran C, Renaudet O, Dumy P, Driguez H, Fort S, Cosnier S. Electrochemical detection of Arachis hypogaea (peanut) agglutinin binding to monovalent and clustered lactosyl motifs immobilized on a polypyrrole film. Chem. Commun. 2005; 4318-4320.
30. Wilczewski M, van der Heyden A, Renaudet O, Dumy P, Coche-Guérente L, Labbé P. Promotion of sugar-lectin recognition through the multiple sugar presentation offered by regioselectively addressable functionalized templates (RAFT): a QCM-D and SPR study. Org. Biomol. Chem. 2008; 6: 1114-1122.
31. Renaudet O, BenMohamed L, Dasgupta G, Bettahi I, Dumy P. Towards self-adjuvanting multivalent B and T cell epitopes synthetic glyco-lipopeptide cancer vaccine. ChemMedChem 2008; 3: 737-741.
32. + T cell epitopes. Cancer Immunol. Immunother. 2009; 58: 187-200.
33. Renaudet O, Křenek K, Bossu I, Dumy P, Kádek A, Adámek D, Vaněk O, Kavan D, Gažák R, Šulc M, Bezouška K, Koen V. Synthesis of multivalent glycoconjugates containing the immunoactive LELTE peptide: effect of glycosylation on cellular activation and natural killing by human peripheral blood mononuclear cells. J. Am. Chem. Soc. 2010; 132: 6800-6808.
34. André S, Maljaars CEP, Halkes KM, Gabius H-J, Kamerling JP. Discovery of galectin ligands in fully randomized combinatorial one-bead-one-compound (glyco)peptide libraries. Bioorg. Med. Chem. Lett. 2007; 17: 793-798.
35. Jiménez-Barbero J, Dragoni E, Venturi C, Nannucci F, Ardá A, Fontanella M, André S, Cañada FJ, Gabius H-J, Nativi C. α-O-Linked glycopeptide mimetics: synthesis, conformation analysis, and interactions with viscumin, a galactoside-binding model lectin. Chem. Eur. J. 2009; 15: 10423-10431.
36. Gabius H-J, Schröter C, Gabius S, Brinck U, Tietze LF. Binding of T-antigen-bearing neoglycoprotein and peanut agglutinin to cultured tumor cells and breast carcinomas. J. Histochem. Cytochem. 1990; 38: 1625-1631.
37. Nagy N, Legendre H, Engels O, André S, Kaltner H, Wasano K, Zick Y, Pector JC, Decaestecker C, Gabius H-J, Salmon I, Kiss R. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer 2003; 97: 1849-1858.
38. Wu AM, Wu JH, Liu J-H, Singh T, André S, Kaltner H, Gabius H-J. Effects of polyvalency of glycotopes and natural modifications of human blood group ABH/Lewis sugars at the Galβ1-terminated core saccharides on the binding of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochimie 2004; 86: 317-326.
39. Gabius H-J. Probing the cons and pros of lectin-induced immunomodulation: case studies for the mistletoe lectin and galectin-1. Biochimie 2001; 83: 659-666.
40. Ahmad N, Gabius H-J, André S, Kaltner H, Sabesan S, Roy R, Liu B, Macaluso F, Brewer CF. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 2004; 279: 10841-10847.
41. Villalobo A, Nogales-González A, Gabius H-J. A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci. Glycotechnol. 2006; 18: 1-37.
42. Kopitz J, Bergmann M, Gabius H-J. How adhesion/growth-regulatory galectins-1 and -3 attain cell specificity: case study defining their target on neuroblastoma cells (SK-N-MC) and marked affinity regulation by affecting microdomain organization of the membrane. IUBMB Life 2010; 62: 624-628.
43. Dam TK, Gabius H-J, André S, Kaltner H, Lensch M, Brewer CF. Galectins bind to the multivalent glycoprotein asialofetuin with enhanced affinities and a gradient of decreasing binding constants. Biochemistry 2005; 44: 12564-12571.
44. INK4a-modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 2007; 274: 3233-3256.
45. INK4a: downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model. FEBS J. 2010; 277: 3552-3563.
46. Duléry V, Renaudet O, Dumy P. Ethoxyethylidene protecting group prevents N-overacylation in aminooxy peptide synthesis. Tetrahedron 2007; 63: 11952-11958.
47. Gabius H-J. Influence of type of linkage and spacer on the interaction of β-galactoside-binding proteins with immobilized affinity ligands. Anal. Biochem. 1990; 189: 91-94.
48. Kübler D, Hung C-W, Dam TK, Kopitz J, André S, Kaltner H, Lohr M, Manning JC, He L, Wang H, Middelberg A, Brewer CF, Reed J, Lehmann W-D, Gabius H-J. Phosphorylated human galectin-3: facile large-scale preparation of active lectin and detection of structural changes by CD spectroscopy. Biochim. Biophys. Acta 2008; 1780: 716-722.
49. Purkrábková T, Smetana K Jr, Dvoránková B, Holíková Z, Böck C, Lensch M, André S, Pytlík R, Liu FT, Klíma J, Smetana K, Motlík J, Gabius H-J. New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biol. Cell 2003; 95: 535-545.
50. André S, Pei Z, Siebert H-C, Ramström O, Gabius H-J. Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations. Bioorg. Med. Chem. 2006; 14: 6314-6326.
51. André S, Kožár T, Schuberth R, Unverzagt C, Kojima S, Gabius H-J. Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties. Biochemistry 2007; 46: 6984-6995.
52. Kaltner H, Solís D, André S, Lensch M, Manning JC, Mürnseer M, Sáiz JL, Gabius H-J. Unique chicken tandem-repeat-type galectin: implications of alternative splicing and a distinct expression profile compared to those of the three proto-type proteins. Biochemistry 2009; 48: 4403-4416.
53. André S, Velasco-Torrijos T, Leyden R, Gouin S, Tosin M, Murphy PV, Gabius H-J. Phenylenediamine-based bivalent glycocyclophanes: synthesis and analysis of the influence of scaffold rigidity and ligand spacing on lectin binding in cell systems with different glycomic profiles. Org. Biomol. Chem. 2009; 7: 4715-4725.
54. Roy R. In Carbohydrate Chemistry, Boons GJ (ed.). London: Blackie Academic & Professional: 1998; 243-321.
55. Renaudet O, Boturyn D, Dumy P. Biomolecular assembly by iterative oxime ligations. Bioorg. Med. Chem. Lett. 2009; 19: 3880-3883.
56. Cao S, Tropper FD, Roy R. Stereoselective phase transfer catalyzed syntheses of glycosyloxysuccinimides and their transformations into glycoprobes. Tetrahedron 1995; 51: 6679-6686.
57. Renaudet O, Dumy P. Expedient synthesis of aminooxylated carbohydrates for chemoselective access of glycoconjugates. Tetrahedron Lett. 2001; 42: 7575-7578.
58. n and T antigenic structures. Carbohydr. Res. 1995; 268: 17-34.
59. Renaudet O, Dumy P. Synthesis of multivalent chemoselectively template-assembled glycopeptide presenting the cancer-related T-antigen. Tetrahedron Lett. 2004; 45: 65-68.
60. Gupta D, Kaltner H, Dong X, Gabius H-J, Brewer CF. Comparative cross-linking activities of lactose-specific plant and animal lectins and a natural lactose-binding immunoglobulin G fraction from human serum with asialofetuin. Glycobiology 1996; 6: 843-849.
61. Goldstein IJ, Poretz RD. In The Lectins. Properties, Functions and Applications in Biology and Medicine, Liener IE, Sharon N, Goldstein IJ (eds). Orlando: Academic Press: 1986; 33-249.
62. Lee RT, Gabius H-J, Lee YC. Ligand binding characteristics of the major mistletoe lectin. J. Biol. Chem. 1992; 267: 23722-23727.
63. Galanina OE, Kaltner H, Khraltsova LS, Bovin NV, Gabius H-J. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency. J. Mol. Recognit. 1997; 10: 139-147.
64. Göhler A, André S, Kaltner H, Sauer M, Gabius H-J, Doose S. Hydrodynamic properties of human adhesion/growth-regulatory galectins studied by fluorescence correlation spectroscopy. Biophys. J. 2010; 98: 3044-3053.
65. André S, Specker D, Bovin NV, Lensch M, Kaltner H, Gabius H-J, Wittmann V. Carbamate-linked lactose: design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells. Bioconjug. Chem. 2009; 20: 1716-1728.
66. Patsos G, André S, Roeckel N, Gromes R, Gebert J, Kopitz J, Gabius H-J. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile. Glycobiology 2009; 19: 726-734.
67. Schwartz-Albiez R. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 447-467.
68. André S, Kojima S, Gundel G, Russwurm R, Schratt X, Unverzagt C, Gabius H-J. Branching mode in complex-type triantennary N-glycans as regulatory element of their ligand properties. Biochim. Biophys. Acta 2006; 1760: 768-782.
69. Gabius H-J, Bodanowitz S, Schauer A. Endogenous sugar-binding proteins in human breast tissue and benign and malignant breast lesions. Cancer 1988; 61: 1125-1131.
70. Tietze LF, Schröter C, Gabius S, Brinck U, Goerlach-Graw A, Gabius H-J. Conjugation of p-aminophenyl glycosides with squaric acid diester to a carrier protein and the use of neoglycoprotein in the histochemical detection of lectins. Bioconjug. Chem. 1991; 2: 148-153.
71. Gabius H-J, Gabius S, Zemlyanukhina TV, Bovin NV, Brinck U, Danguy A, Joshi SS, Kayser K, Schottelius J, Sinowatz F, Tietze LF, Vidal-Vanaclocha F, Zanetta JP. Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. Histol. Histopathol. 1993; 8: 369-383.
72. Schwefel D, Maierhofer C, Beck JG, Seeberger S, Diederichs K, Möller HM, Welte W, Wittmann V. Structural basis of multivalent binding to wheat germ agglutinin. J. Am. Chem. Soc. 2010; 132: 8704-8719.
73. André S, Ortega PJC, Perez MA, Roy R, Gabius H-J. Lactose-containing starburst dendrimers: influence of dendrimer generation and binding-site orientation of receptors (plant/animal lectins and immunoglobulins) on binding properties. Glycobiology 1999; 9: 1253-1261.
74. André S, Liu B, Gabius H-J, Roy R. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside. Org. Biomol. Chem. 2003; 1: 3909-3916.
75. Ahmad N, Gabius H-J, Kaltner H, André S, Kuwabara I, Liu F-T, Oscarson S, Norberg T, Brewer CF. Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3, and -7: evidence for differential binding specificities. Can. J. Chem. 2002; 80: 1096-1104.
76. Wu AM, Wu JH, Tsai M-S, Liu J-H, André S, Wasano K, Kaltner H, Gabius H-J. Fine specificity of domain-I of recombinant tandem-repeat-type galectin-4 from rat gastrointestinal tract (G4-N). Biochem. J. 2002; 367: 653-664.
77. Szabo P, Dam TK, Smetana K Jr, Dvooánková B, Kübler D, Brewer CF, Gabius HJ. Phosphorylated human lectin galectin-3: analysis of ligand binding by histochemical monitoring of normal/malignant squamous epithelia and by isothermal titration calorimetry. Anat. Histol. Embryol. 2009; 38: 68-75.
78. André S, Giguère D, Dam TK, Brewer F, Gabius H-J, Roy R. Synthesis and screening of a small glycomimetic library for inhibitory activity on medically relevant galactoside-specific lectins in assays of increasing biorelevance. New J. Chem. 2010; 34: 2229-2240.
79. Ribeiro JP, André S, Cañada FJ, Gabius H-J, Butera AP, Alves RJ, Jiménez-Barbero J. Lectin-based drug design: combined strategy to identify lead compounds using STD NMR spectroscopy, solid-phase assays and cell binding for a plant toxin model. ChemMedChem 2010; 5: 415-419.
80. Gready JE, Zelensky AN. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 329-346.
81. Holgersson J, Gustafsson A, Gaunitz S. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 279-300.
82. Osborn HMI, Turkson A. In The Sugar Code. Fundamentals of Glycosciences, Gabius H-J (ed.). Weinheim: Wiley-VCH: 2009; 469-483.